KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exelon (EXC) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Exelon (EXC) over the last 17 years, with Q4 2025 value amounting to $1.0 billion.

  • Exelon's Shares Outstanding (Weighted Average) rose 79.76% to $1.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.0 billion, marking a year-over-year increase of 79.76%. This contributed to the annual value of $1.0 billion for FY2025, which is 79.76% up from last year.
  • Per Exelon's latest filing, its Shares Outstanding (Weighted Average) stood at $1.0 billion for Q4 2025, which was up 79.76% from $1.0 billion recorded in Q3 2025.
  • Over the past 5 years, Exelon's Shares Outstanding (Weighted Average) peaked at $1.0 billion during Q3 2025, and registered a low of $977.0 million during Q1 2021.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $993.9 million, with a median of $995.5 million in 2023.
  • In the last 5 years, Exelon's Shares Outstanding (Weighted Average) increased by 20.49% in 2021 and then surged by 142.71% in 2023.
  • Quarter analysis of 5 years shows Exelon's Shares Outstanding (Weighted Average) stood at $979.0 million in 2021, then increased by 0.72% to $986.0 million in 2022, then grew by 1.01% to $996.0 million in 2023, then increased by 0.7% to $1.0 billion in 2024, then grew by 0.8% to $1.0 billion in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $1.0 billion for Q4 2025, versus $1.0 billion for Q3 2025 and $1.0 billion for Q2 2025.